高级检索
当前位置: 首页 > 详情页

Circ_0001953 contribute to retinal vascular endothelial cell injury induced by high glucose through regulating miR-186

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Fourth Hosp Hebei Med Univ, Dept Ophthalmol, Shijiazhuang 050000, Hebei, Peoples R China [2]Shijiazhuang peoples Hosp, Dept Ophthalmol, Shijiazhuang 050003, Hebei, Peoples R China
出处:
ISSN:

关键词: circ_0001953 miR-186 HRVECs inflammation oxidative stress apoptosis

摘要:
Purpose: To investigate the effects of circ_0001953/miR-186 on human retinal vascular endothelial cell (HRVEC) injury evoked by high glucose. Methods: A cell model (HG group) was established using high glucose-treated HRVECs, while untreated HRVECs were used as the control group (Con group). The levels of endothelin-1 (ET-1), ICAM-1 and IL-6 were evaluated by ELISA and the content of malondialdehyde (MDA) and superoxide dismutase (SOD) in HRVECs were determined. Apoptosis rate was tested adopting flow cytometry. The interrelationship between circ_0001953 and miR-186 was assessed using dual luciferase reporter assay. Measurement of Bax and Bcl-2 was implemented via western blot. Results: In HG group, circ_0001953 increased while miR-186 was downregulated, ET-1, IL-6, ICAM-1, and apoptosis rate increased and accompanied with up-regulated Bax content and declined Bcl-2 protein level. Furthermore, the content of MDA increased and SOD decreased. MiR-186 was a target of circ_0001953. Conclusion: Inhibition of circ_0001953 can repress inflammation, oxidative stress and apoptosis in HRVECs by up-regulating the expression of miR-186.

语种:
WOS:
中科院分区:
出版当年[2023]版:
大类 | 4 区 医学
小类 | 4 区 药学
最新[2025]版:
JCR分区:
出版当年[2023]版:
Q4 PHARMACOLOGY & PHARMACY
最新[2024]版:

影响因子: 最新[2024版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者:
第一作者机构: [1]Fourth Hosp Hebei Med Univ, Dept Ophthalmol, Shijiazhuang 050000, Hebei, Peoples R China
通讯作者:
通讯机构: [1]Fourth Hosp Hebei Med Univ, Dept Ophthalmol, Shijiazhuang 050000, Hebei, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:42329 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号